- abnormal bone structure / IMPC
- increased circulating glucose level / IMPC
- abnormal optic disk morphology / IMPC
- abnormal clavicle morphology / IMPC
- abnormal joint morphology / IMPC
- increased large unstained cell number / IMPC
- increased eosinophil cell number / IMPC
- increased leukocyte cell number / IMPC
C57BL/6N-Mapkapk2tm1a(EUCOMM)Hmgu/H
Status | Available to order |
EMMA ID | EM:05658 |
Citation information | RRID:IMSR_EM:05658 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Mapkapk2tm1a(EUCOMM)Hmgu/H |
Alternative name | HEPD0672_2_A02 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Mapkapk2tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | Mapkapk2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0672_2_A02. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Animals used for archiving | heterozygous C57BL/6NTac males |
Breeding at archiving centre | Chimeras were crossed to C57BL/6N Tac USA and maintained on this background thereafter. |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- altered response to myocardial infarction / MGI
- impaired macrophage phagocytosis / MGI
- no abnormal phenotype detected / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal cytokine secretion / MGI
- decreased myocardial infarction size / MGI
- decreased cardiomyocyte apoptosis / MGI
- abnormal macrophage derived foam cell morphology / MGI
- increased spleen germinal center size / MGI
- decreased circulating tumor necrosis factor level / MGI
- decreased tumor necrosis factor secretion / MGI
- decreased interferon-gamma secretion / MGI
- increased interleukin-1 beta secretion / MGI
- abnormal cytokine level / MGI
- decreased susceptibility to endotoxin shock / MGI
- increased susceptibility to bacterial infection induced morbidity/mortality / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).